DCLK1 Regulates Tumor Stemness and Cisplatin Resistance in Non-small Cell Lung Cancer via ABCD-Member-4

Chemoresistance cells have features similar to cancer stem cells. Elimination of these cells is an effective therapeutic strategy to clinically combat chemoresistance non-small cell lung cancer (NSCLC). Here, we demonstrate that Doublecortin-like kinase1 (DCLK1) is the key to developing chemoresista...

Descripción completa

Detalles Bibliográficos
Autores principales: Panneerselvam, Janani, Mohandoss, Priyanga, Patel, Ravi, Gillan, Hamza, Li, Michael, Kumar, Kirtana, Nguyen, DangHuy, Weygant, Nathaniel, Qu, Dongfeng, Pitts, Kamille, Lightfoot, Stanley, Rao, Chinthalapally, Houchen, Courtney, Bronze, Michael, Chandrakesan, Parthasarathy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7321820/
https://www.ncbi.nlm.nih.gov/pubmed/32637578
http://dx.doi.org/10.1016/j.omto.2020.05.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7321820/
https://www.ncbi.nlm.nih.gov/pubmed/32637578
http://dx.doi.org/10.1016/j.omto.2020.05.012

Ejemplares similares